162 related articles for article (PubMed ID: 7499788)
1. Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94.
Chenoufi N; Hubert N; Loréal O; Morel I; Pasdeloup N; Cillard J; Brissot P; Lescoat G
J Hepatol; 1995 Aug; 23(2):166-73. PubMed ID: 7499788
[TBL] [Abstract][Full Text] [Related]
2. Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study.
Gaboriau F; Chantrel-Groussard K; Rakba N; Loyer P; Pasdeloup N; Hider RC; Brissot P; Lescoat G
Biochem Pharmacol; 2004 Apr; 67(8):1479-87. PubMed ID: 15041465
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine.
Morel I; Cillard J; Lescoat G; Sergent O; Pasdeloup N; Ocaktan AZ; Abdallah MA; Brissot P; Cillard P
Free Radic Biol Med; 1992 Nov; 13(5):499-508. PubMed ID: 1334028
[TBL] [Abstract][Full Text] [Related]
4. Cytoprotection and iron mobilization in rat hepatocyte cultures by a new synthetic dihydroxamate chelator.
Rakba N; Nguyen-Van-Duong MK; Nicolas L; Guillot V; Morel I; Pasdeloup N; Brissot P; Lescoat G
Toxicol Lett; 1999 Oct; 110(1-2):19-27. PubMed ID: 10593591
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro effects of 3-hydroxypyridin-4-one chelators on murine hemopoiesis.
Hoyes KP; Jones HM; Abeysinghe RD; Hider RC; Porter JB
Exp Hematol; 1993 Jan; 21(1):86-92. PubMed ID: 8417963
[TBL] [Abstract][Full Text] [Related]
6. Contrasting interspecies efficacy and toxicology of 1,2-diethyl-3-hydroxypyridin-4-one, CP94, relates to differing metabolism of the iron chelating site.
Porter JB; Abeysinghe RD; Hoyes KP; Barra C; Huehns ER; Brooks PN; Blackwell MP; Araneta M; Brittenham G; Singh S
Br J Haematol; 1993 Sep; 85(1):159-68. PubMed ID: 8251385
[TBL] [Abstract][Full Text] [Related]
7. Urinary metabolic profiles in human and rat of 1,2-dimethyl- and 1,2-diethyl-substituted 3-hydroxypyridin-4-ones.
Singh S; Epemolu RO; Dobbin PS; Tilbrook GS; Ellis BL; Damani LA; Hider RC
Drug Metab Dispos; 1992; 20(2):256-61. PubMed ID: 1352218
[TBL] [Abstract][Full Text] [Related]
8. EPR study of antioxidant activity of the iron chelators pyoverdin and hydroxypyrid-4-one in iron-loaded hepatocyte culture: comparison with that of desferrioxamine.
Morel I; Sergent O; Cogrel P; Lescoat G; Pasdeloup N; Brissot P; Cillard P; Cillard J
Free Radic Biol Med; 1995 Feb; 18(2):303-10. PubMed ID: 7744315
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of iron toxicity in human hepatocyte cultures by pyoverdins Pa A and Pf, the peptidic siderophores of Pseudomonas aeruginosa and fluorescens.
Jégo P; Chenoufi N; Loréal O; Morel I; Pasdeloup N; Abdallah MA; Brissot P; Lescoat G
Liver; 1997 Apr; 17(2):70-5. PubMed ID: 9138275
[TBL] [Abstract][Full Text] [Related]
10. Effect of iron overload on the metabolism and urinary recovery of 3-hydroxypyridin-4-one chelating agents in the rat.
Choudhury R; Singh S
Drug Metab Dispos; 1995 Mar; 23(3):314-20. PubMed ID: 7628295
[TBL] [Abstract][Full Text] [Related]
11. Studies of in vivo iron mobilization by chelators in the ferrocene-loaded rat.
Florence A; Ward RJ; Peters TJ; Crichton RR
Biochem Pharmacol; 1992 Sep; 44(6):1023-7. PubMed ID: 1417929
[TBL] [Abstract][Full Text] [Related]
12. Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats.
Zanninelli G; Choudury R; Loréal O; Guyader D; Lescoat G; Arnaud J; Verna R; Cosson B; Singh S; Hider RC; Brissot P
J Hepatol; 1997 Jul; 27(1):176-84. PubMed ID: 9252093
[TBL] [Abstract][Full Text] [Related]
13. Multidentate pyridinones inhibit the metabolism of nontransferrin-bound iron by hepatocytes and hepatoma cells.
Chua AC; Ingram HA; Raymond KN; Baker E
Eur J Biochem; 2003 Apr; 270(8):1689-98. PubMed ID: 12694182
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative and apoptotic effects in rat and human hepatoma cell cultures of the orally active iron chelator ICL670 compared to CP20: a possible relationship with polyamine metabolism.
Lescoat G; Chantrel-Groussard K; Pasdeloup N; Nick H; Brissot P; Gaboriau F
Cell Prolif; 2007 Oct; 40(5):755-67. PubMed ID: 17877614
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethly-, 1,2 diethyl-, and 1-[ethan-1'ol]-2-methyl-3-hydroxypyridin-4-one in the rat.
Fredenburg AM; Sethi RK; Allen DD; Yokel RA
Toxicology; 1996 Apr; 108(3):191-9. PubMed ID: 8658538
[TBL] [Abstract][Full Text] [Related]
16. Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools.
Hoyes KP; Porter JB
Br J Haematol; 1993 Oct; 85(2):393-400. PubMed ID: 8280612
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative effect of deferiprone on the Hep G2 cell line.
Chenoufi N; Drénou B; Loréal O; Pigeon C; Brissot P; Lescoat G
Biochem Pharmacol; 1998 Aug; 56(4):431-7. PubMed ID: 9763218
[TBL] [Abstract][Full Text] [Related]
18. Iron mobilisation and cellular protection by a new synthetic chelator O-Trensox.
Rakba N; Aouad F; Henry C; Caris C; Morel I; Baret P; Pierre JL; Brissot P; Ward RJ; Lescoat G; Crichton RR
Biochem Pharmacol; 1998 Jun; 55(11):1797-806. PubMed ID: 9714298
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of iron overload toxicity in rat hepatocyte cultures by pyoverdin Pf, the siderophore of Pseudomonas fluorescens.
Jego P; Hubert N; Morel I; Pasdeloup N; Ocaktan A; Abdallah M; Brissot P; Lescoat G
Biochem Pharmacol; 1992 Mar; 43(6):1275-80. PubMed ID: 1562281
[TBL] [Abstract][Full Text] [Related]
20. Effects of chelators on iron uptake and release by the brain in the rat.
Crowe A; Morgan EH
Neurochem Res; 1994 Jan; 19(1):71-6. PubMed ID: 8139766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
